Open-access Systemic sarcoidosis induced by etanercept: first Brazilian case report*

Sarcoidose sistêmica induzida por etanercepte: primeiro relato de caso brasileiro

Abstract

The antagonists of tumor necrosis factor alpha (TNF-α) are increasingly being used in the treatment of inflammatory and autoimmune diseases. Several adverse effects of these drugs have been reported, including the paradoxical development of sarcoidosis, especially with the use of etanercept. We present the first Brazilian case report of systemic sarcoidosis induced by etanercept and a literature review.

Diagnosis; Granuloma; Sarcoidosis; Tumor necrosis factor-alpha


location_on
Sociedade Brasileira de Dermatologia Av. Rio Branco, 39 18. and., 20090-003 Rio de Janeiro RJ, Tel./Fax: +55 21 2253-6747 - Rio de Janeiro - RJ - Brazil
E-mail: revista@sbd.org.br
rss_feed Acompañe los números de esta revista en su lector de RSS
Ir para arriba Notificar error